Pioneering the Future of Infection Control
Advanced HOCl-Based Solutions That Remain Effective Where Traditional Antimicrobials Fail
Revolutionizing Infection Care
Pioneering the Future of Infection Control
Spectrum Antimicrobials develops next-generation medical devices and drug candidates engineered to overcome the critical limitations of conventional infection control, remaining stable and effective in the presence of blood serum, biofilms, and challenging clinical environments.
2018 - Research
Spectrum Antimicrobials was founded to address the urgent global need for development of effective antimicrobial and antiviral solutions, including medical device and therapeutics. The research team successfully screened more than 900 distinct chemistries leading to the creation of Tri-Ion™ chemistry.
2019 — GMP Manufacturing Facility Established
Opened a 14,000 sq. ft. FDA‑registered cGMP manufacturing headquarters in Petaluma, California, with a dedicated research and development facility.
2023 - Securing first regulatory approvals / clearance
Spectricept™ Hand Sanitizer was approved for sale within the UK NHS hospital system. Spectricept™ Skin and Wound Cleanser received FDA clearance for sale in the U.S. prescription and OTC markets.
2024 - 510(K) clearance
Spectricept™ Skin and Wound Cleanser received a second 510(k) clearance without use restrictions.
2025 - Proteomics program
The company advanced its proteomics program to expand therapeutic chemistries beyond current HOCl limitations.
Innovative Infection Care
Leadership Committed to Scientific Excellence
Our multidisciplinary team combines deep expertise in microbiology, chemistry, regulatory affairs, and clinical medicine.
Executive Team

Hoji Alimi
Founder, Chairman, CEO Head of product Development

Bill Watson
Co-founder, Executive VP of Strategic Business Alliances
Management Team

Stephanie Alimi
Senior Director of Operations and Manufacturing

Antoinette Douglas
Senior Director of Regulatory Affairs and Quality Assurance

Jerry Stonemetz MD
Medical Affairs Director

Ernie Bravoe
Director of Marketing

Jim Lodigiani
Director of Sales

Sameer Harish
Director of Finance

James Stanley
Director of Business Dev

Diana Watson
Director of Business Dev

Greg Madick
Controller
Engineering and Operations Team

Will Smith
Manufacturing Engineer

Larry Rogers
Manufacturing engineer

Brean Aquino
Manufacturing Engineer
Quality Assurance and Control

Gayathri Lekha Nair
Quality Engineering

Nicholas Alimi
Quality Control and R&D Microbiologist

Pablo Fernandez
Quality Assurance Manager
Research and Development

Mohammad Esmaeili
Co-founder and VP of Engineering and Chemistry R&D

Hoji Alimi
Head of Product Innovation

Nicholas Alimi
Microbiologist

Demsin Bet Adam
Protein Chemistry
Principles Driving Our Mission
At Spectrum Antimicrobials, scientific rigor guides every decision—our formulations undergo rigorous independent testing to validate safety, efficacy, and stability in real-world clinical conditions. We develop patient-centered solutions that address unmet clinical needs while reducing infection risk for patients and healthcare workers. Committed to responsible stewardship, our chemistries eradicate pathogens without promoting antimicrobial resistance, preserving antibiotic effectiveness for future generations. Through transparent collaboration with clinical researchers, regulatory bodies, and industry partners, we advance infection control science that makes a measurable difference in global healthcare.
- Scientific Rigor
- Patient-Centered Innovation
- Responsible Stewardship
- Partnership & Transparency
Infection Care Leadership
Advancing Infection Control Through Chemistry
- Proprietary Tri-Ion™ platform and chemistries with demonstrated activity against antibiotic-resistant bacteria, viruses, fungi, and spores
- Demonstrated stability in 5% serum and whole blood, including performance at near-freezing temperatures—addressing traditional HOCl limitations
- FDA-cleared medical devices and advancing drug candidates for the treatment of upper and lower respiratory infections, wound care, and urinary tract infections (UTIs)